tiprankstipranks
Trending News
More News >
Kane Biotech Inc (TSE:KNE)
:KNE
Canadian Market
Advertisement

Kane Biotech (KNE) Income Statement

Compare
1 Followers

Kane Biotech Income Statement

Last quarter (Q1 2025), Kane Biotech's total revenue was C$412.51K, an increase of 695.04% from the same quarter last year. In Q1, Kane Biotech's net income was C$-1.22M. See Kane Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 2.08MC$ 148.98KC$ 2.67MC$ 1.61MC$ 1.34M
Gross Profit
C$ 653.63KC$ 109.47KC$ 1.41MC$ 568.44KC$ 526.86K
Operating Expenses
C$ 4.80MC$ 3.47MC$ 4.78MC$ 5.45MC$ 4.75M
Depreciation and Amortization
C$ 218.47KC$ 116.05KC$ 257.68KC$ 187.97KC$ 78.11K
EBITDA
C$ -3.71MC$ -3.23MC$ -2.95MC$ -4.25MC$ -3.65M
Operating Income
C$ -4.49MC$ -3.36MC$ -3.36MC$ -4.88MC$ -4.22M
Other Income/Expenses
C$ 22.60KC$ -1.20MC$ -564.03KC$ 33.65KC$ 378.40K
Pretax Income
C$ -4.47MC$ -4.56MC$ -3.82MC$ -4.85MC$ -3.85M
Net Income
C$ -3.02MC$ -5.03MC$ -3.89MC$ -4.60MC$ -3.72M
Per Share Metrics
Basic EPS
C$ -0.02C$ -0.04C$ -0.03C$ -0.04C$ -0.03
Diluted EPS
C$ -0.02C$ -0.04C$ -0.03C$ -0.04C$ -0.03
Weighted Average Shares Outstanding
133.91M 140.26M 120.70M 112.60M 107.55M
Weighted Average Shares Outstanding (Diluted)
133.91M 127.12M 120.70M 112.60M 107.55M
Currency in CAD

Kane Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis